Variability at the FCGR locus: Characterization in Black South Africans and evidence for ethnic variation in and out of Africa

Genes and Immunity

Volumn 17, Issue 2, 2016, Pages 93-104

  Lassauniere R ^a,b   Tiemessen, C T ^a,b  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

FC GAMMA RECEPTOR 3A; FC GAMMA RECEPTOR 3B; FC RECEPTOR; FC RECEPTOR IIA; FC RECEPTOR IIB; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; UNCLASSIFIED DRUG; FCGR2A PROTEIN, HUMAN; FCGR2B PROTEIN, HUMAN; FCGR2C PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ALLELE; ALLOTYPE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; BLACK PERSON; CAUCASIAN; CELL ACTIVATION; CONTROLLED STUDY; COPY NUMBER VARIATION; ETHNIC DIFFERENCE; EXON; GENE DELETION; GENE DOSAGE; GENE DUPLICATION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; KENYAN; NATURAL KILLER CELL; NETHERLANDS; NIGERIA; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SOUTH AFRICAN; SYNTENY; UNITED KINGDOM; YORUBA (PEOPLE); AFRICA; ETHNOLOGY; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETICS; HIV INFECTIONS; HUMAN GENOME PROJECT; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGY;

AFRICA, SOUTHERN; AFRICAN CONTINENTAL ANCESTRY GROUP; AIDS VACCINES; ALLELES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE EXPRESSION; GENE FREQUENCY; GENETIC LOCI; HAPLOTYPES; HIV INFECTIONS; HIV-1; HUMAN GENOME PROJECT; HUMANS; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, IGG;

EID: 84959516660     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2015.60     Document Type: Article

References (54)

1. Daeron M. Fc receptor biology. Annu Rev Immunol 1997; 15: 203-234.
2. Nimmerjahn F, Ravetch JV. Fc-receptors as regulators of immunity. Adv Immunol 2007; 96: 179-204.
3. Breunis WB, van Mirre E, Geissler J, Laddach N, Wolbink G, van der Schoot E., et al. Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B. Hum Mutat 2009; 30: E640-E650.
4. Willcocks LC, Lyons PA, Clatworthy MR, Robinson JI, Yang W, Newland SA., et al. Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J Exp Med 2008; 205: 1573-1582.
5. Lassauniere R, Shalekoff S, Tiemessen CT. A novel FCGR3A intragenic haplotype is associated with increased FcgammaRIIIa/CD16a cell surface density and population differences. Hum Immunol 2013; 74: 627-634.
6. Su K, Li X, Edberg JC, Wu J, Ferguson P, Kimberly RP. A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. II. Differential binding of GATA4 and Yin-Yang1 transcription factors and correlated receptor expression and function. J Immunol 2004; 172: 7192-7199.
7. Su K, Wu J, Edberg JC, Li X, Ferguson P, Cooper GS., et al. A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus. J Immunol 2004; 172: 7186-7191.
8. Bruhns P, Iannascoli B, England P, Mancardi DA, Fernandez N, Jorieux S., et al. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 2009; 113: 3716-3725.
9. Sanders LA, Feldman RG, Voorhorst-Ogink MM, de Haas M, Rijkers GT, Capel PJ., et al. Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils. Infect Immun 1995; 63: 73-81.
10. Warmerdam PA, van de Winkel JG, Vlug A, Westerdaal NA, Capel PJ. A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. J Immunol 1991; 147: 1338-1343.
11. Wu J, Edberg JC, Redecha PB, Bansal V, Guyre PM, Coleman K., et al. A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 1997; 100: 1059-1070.
12. Floto RA, Clatworthy MR, Heilbronn KR, Rosner DR, MacAry PA, Rankin A., et al. Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nat Med 2005; 11: 1056-1058.
13. Salmon JE, Edberg JC, Kimberly RP. Fc gamma receptor III on human neutrophils. Allelic variants have functionally distinct capacities. J Clin Invest 1990; 85: 1287-1295.
14. Li X, Wu J, Ptacek T, Redden DT, Brown EE, Alarcon GS., et al. Allelic-dependent expression of an activating Fc receptor on B cells enhances humoral immune responses. Sci Transl Med 2013; 5: 216ra175.
15. van der Heijden J, Breunis WB, Geissler J, de Boer M, van den Berg TK, Kuijpers TW. Phenotypic variation in IgG receptors by nonclassical FCGR2C alleles. J Immunol 2012; 188: 1318-1324.
16. Li SS, Gilbert PB, Tomaras GD, Kijak G, Ferrari G, Thomas R., et al. FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial. J Clin Invest 2014; 124: 3879-3890.
17. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R., et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009; 361: 2209-2220.
18. Niederer HA, Willcocks LC, Rayner TF, Yang W, Lau YL, Williams TN., et al. Copy number, linkage disequilibrium and disease association in the FCGR locus. Hum Mol Genet 2010; 19: 3282-3294.
19. Clatworthy MR, Willcocks L, Urban B, Langhorne J, Williams TN, Peshu N., et al. Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria. Proc Natl Acad Sci USA 2007; 104: 7169-7174.
20. Cooke GS, Aucan C, Walley AJ, Segal S, Greenwood BM, Kwiatkowski DP., et al. Association of Fcgamma receptor IIa (CD32) polymorphism with severe malaria in West Africa. Am J Trop Med Hyg 2003; 69: 565-568.
21. Nielsen KR, Koelbaek MD, Varming K, Baech J, Steffensen R. Frequencies of HNA-1, HNA-3, HNA-4, and HNA-5 in the Danish and Zambian populations determined using a novel TaqMan real time polymerase chain reaction method. Tissue antigens 2012; 80: 249-253.
22. Tishkoff SA, Reed FA, Friedlaender FR, Ehret C, Ranciaro A, Froment A., et al. The genetic structure and history of Africans and African Americans. Science 2009; 324: 1035-1044.
23. Tishkoff SA, Williams SM. Genetic analysis of African populations: human evolution and complex disease. Nat Rev Genet 2002; 3: 611-621.
24. McKinney C, Merriman TR. Meta-analysis confirms a role for deletion in FCGR3B in autoimmune phenotypes. Hum Mol Genet 2012; 21: 2370-2376.
25. Willcocks LC, Carr EJ, Niederer HA, Rayner TF, Williams TN, Yang W., et al. A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus. Proc Natl Acad Sci USA 2010; 107: 7881-7885.
26. Cartron G, Dacheux L, Salles G, Solal-Celigny P, Bardos P, Colombat P., et al. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. Blood 2002; 99: 754-758.
27. Mueller M, Barros P, Witherden AS, Roberts AL, Zhang Z, Schaschl H., et al. Genomic pathology of SLE-associated copy-number variation at the FCGR2C/FCGR3B/FCGR2B locus. Am J Hum Genet 2013; 92: 28-40.
28. Chu ZT, Tsuchiya N, Kyogoku C, Ohashi J, Qian YP, Xu SB., et al. Association of Fcgamma receptor IIb polymorphism with susceptibility to systemic lupus erythematosus in Chinese: a common susceptibility gene in the Asian populations. Tissue antigens 2004; 63: 21-27.
29. Siriboonrit U, Tsuchiya N, Sirikong M, Kyogoku C, Bejrachandra S, Suthipinittharm P., et al. Association of Fcgamma receptor IIb and IIIb polymorphisms with susceptibility to systemic lupus erythematosus in Thais. Tissue antigens 2003; 61: 374-383.
30. Li X, Wu J, Carter RH, Edberg JC, Su K, Cooper GS., et al. A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling. Arthritis Rheum 2003; 48: 3242-3252.
31. Bux J, Stein EL, Bierling P, Fromont P, Clay M, Stroncek D., et al. Characterization of a new alloantigen (SH) on the human neutrophil Fc gamma receptor IIIb. Blood 1997; 89: 1027-1034.
32. Matsuhashi M, Tsuno NH, Kawabata M, Mishima Y, Okochi N, Santoso S., et al. The frequencies of human neutrophil alloantigens among the Japanese population. Tissue antigens 2012; 80: 336-340.
33. Tong Y, Jin J, Yan L, Neppert J, Marget M, Flesch BK. FCGR3B gene frequencies and FCGR3 variants in a Chinese population from Zhejiang Province. Ann Hematol 2003; 82: 574-578.
34. Osborne JM, Chacko GW, Brandt JT, Anderson CL. Ethnic variation in frequency of an allelic polymorphism of human Fc gamma RIIA determined with allele specific oligonucleotide probes. J Immunol Methods 1994; 173: 207-217.
35. Kaset C, Leetrakool N, Intharanut K, Nathalang O. Frequency of FCGR3B alleles in Thai blood donors. Ann Lab Med 2013; 33: 426-430.
36. Adu B, Dodoo D, Adukpo S, Hedley PL, Arthur FK, Gerds TA., et al. Fc gamma receptor IIIB (FcgammaRIIIB) polymorphisms are associated with clinical malaria in Ghanaian children. PLoS One 2012; 7: e46197.
37. Ernst LK, Metes D, Herberman RB, Morel PA. Allelic polymorphisms in the FcgammaRIIC gene can influence its function on normal human natural killer cells. J Mol Med (Berl) 2002; 80: 248-257.
38. Vance BA, Huizinga TW, Wardwell K, Guyre PM. Binding of monomeric human IgG defines an expression polymorphism of Fc gamma RIII on large granular lymphocyte/natural killer cells. J Immunol 1993; 151: 6429-6439.
39. Sirugo G, Hennig BJ, Adeyemo AA, Matimba A, Newport MJ, Ibrahim ME., et al. Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics. Hum Genet 2008; 123: 557-598.
40. Kwiatkowski DP. How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet 2005; 77: 171-192.
41. Bournazos S, Woof JM, Hart SP, Dransfield I. Functional and clinical consequences of Fc receptor polymorphic and copy number variants. Clin Exp Immunol 2009; 157: 244-254.
42. Korbet SM, Schwartz MM, Evans J, Lewis EJ, Collaborative Study Group. Severe lupus nephritis: racial differences in presentation and outcome. J Am Soc Nephrol 2007; 18: 244-254.
43. Lau CS, Yin G, Mok MY. Ethnic and geographical differences in systemic lupus erythematosus: an overview. Lupus 2006; 15: 715-719.
44. Breunis WB, van Mirre E, Bruin M, Geissler J, de Boer M, Peters M., et al. Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura. Blood 2008; 111: 1029-1038.
45. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002; 30: e57.
46. den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 2000; 15: 7-12.
47. Ferrari G, Pollara J, Kozink D, Harms T, Drinker M, Freel S., et al. An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum. J Virol 2011; 85: 7029-7036.
48. Moore JP, Thali M, Jameson BA, Vignaux F, Lewis GK, Poon SW., et al. Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop. J Virol 1993; 67: 4785-4796.
49. Wyatt R, Moore J, Accola M, Desjardin E, Robinson J, Sodroski J. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. J Virol 1995; 69: 5723-5733.
50. Howell DN, Andreotti PE, Dawson JR, Cresswell P. Natural killing target antigens as inducers of interferon: studies with an immunoselected, natural killing-resistant human T lymphoblastoid cell line. J Immunol 1985; 134: 971-976.
51. Lyerly HK, Reed DL, Matthews TJ, Langlois AJ, Ahearne PA, Petteway SR Jr., et al. Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC. AIDS Res Hum Retroviruses 1987; 3: 409-422.
52. Pollara J, Hart L, Brewer F, Pickeral J, Packard BZ, Hoxie JA., et al. High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses. Cytometry A 2011; 79: 603-612.
53. Haldane JBS. An exact test for randomness of mating. J Genet 1954; 52: 631-635.
54. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.